Collected Study on Immunology, 1906. ,
Multifunctional nanocarriers???, Advanced Drug Delivery Reviews, vol.58, issue.14, pp.1532-1555, 2006. ,
DOI : 10.1016/j.addr.2006.09.009
The origins and evolution of ???controlled??? drug delivery systems, Journal of Controlled Release, vol.132, issue.3, pp.153-163, 2008. ,
DOI : 10.1016/j.jconrel.2008.08.012
Polymer-Based Therapeutics, Macromolecules, vol.42, issue.1, pp.3-13, 2009. ,
DOI : 10.1021/ma801782q
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer, Trends in Pharmacological Sciences, vol.30, issue.11, pp.592-599, 2009. ,
DOI : 10.1016/j.tips.2009.08.004
Cancer nanotechnology: application of nanotechnology in cancer therapy, Drug Discovery Today, vol.15, issue.19-20, pp.842-850, 2010. ,
DOI : 10.1016/j.drudis.2010.08.006
Polymeric nanomedicine for cancer therapy, Progress in Polymer Science, vol.33, issue.1, pp.113-137, 2008. ,
DOI : 10.1016/j.progpolymsci.2007.09.003
Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications, Nanomedicine, vol.3, issue.3, pp.367-393, 2008. ,
DOI : 10.2217/17435889.3.3.367
An unusual polyanion from Physarum polycephalum that inhibits homologous DNA-polymerase .alpha. in vitro, Biochemistry, vol.28, issue.12, pp.28-5219, 1989. ,
DOI : 10.1021/bi00438a045
Natural poly(L-malic acid): NMR shows a poly(3-hydroxy acid)-type structure, Macromolecules, vol.26, issue.17, pp.4681-4684, 1993. ,
DOI : 10.1021/ma00069a041
Ionic Complexes of Biotechnological Polyacids with Cationic Surfactants, Macromolecular Symposia, vol.7, issue.1, 2008. ,
DOI : 10.1002/masy.200851312
Poly(methyl malate) Nanoparticles: Formation, Degradation, and Encapsulation of Anticancer Drugs, Macromolecular Bioscience, vol.5, issue.10, pp.1370-1377, 2011. ,
DOI : 10.1002/mabi.201100107
Modification of Microbial Polymalic Acid With Hydrophobic Amino Acids for Drug-Releasing Nanoparticles, Macromolecular Chemistry and Physics, vol.5, issue.15, pp.1623-1631, 2012. ,
DOI : 10.1002/macp.201200134
Ionic Complexes of Biosynthetic Poly(malic acid) and Poly(glutamic acid) as Prospective Drug-Delivery Systems, Macromolecular Bioscience, vol.23, issue.7, pp.897-906, 2007. ,
DOI : 10.1002/mabi.200700025
Synthesis, Degradability, and Drug Releasing Properties of Methyl Esters of Fungal Poly(??,L-malic acid), Macromolecular Bioscience, vol.7, issue.6, pp.540-550, 2008. ,
DOI : 10.1002/mabi.200700248
Polymalic acid based nanoconjugate for imaging, 2012. ,
Poly(beta-malic acid) with pendant leu-leu-leu tripeptide for effective cytoplasmic drug delivery, 2009. ,
Inhibition of brain tumor growth by intravenous poly(??-L-malic acid) nanobioconjugate with pH-dependent drug release, Proceedings of the National Academy of Sciences, vol.107, issue.42, pp.107-18143, 2010. ,
DOI : 10.1073/pnas.1003919107
The optimization of polymalic acid peptide copolymers for endosomolytic drug delivery, Biomaterials, vol.32, issue.22, pp.5269-5278, 2011. ,
DOI : 10.1016/j.biomaterials.2011.03.073
Distinct mechanisms of membrane permeation induced by two polymalic acid copolymers, Biomaterials, vol.34, issue.1, pp.217-225, 2013. ,
DOI : 10.1016/j.biomaterials.2012.08.016
Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer, J Control Release, issue.3, pp.171-322, 2013. ,
Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis, Angiogenesis, vol.438, issue.4, pp.183-191, 2006. ,
DOI : 10.1007/s10456-006-9046-9
Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(??-l-malic acid), Journal of Controlled Release, vol.122, issue.3, pp.356-363, 2007. ,
DOI : 10.1016/j.jconrel.2007.05.032
Polymalic Acid-Based Nanobiopolymer Provides Efficient Systemic Breast Cancer Treatment by Inhibiting both HER2/neu Receptor Synthesis and Activity, Cancer Research, vol.71, issue.4, pp.1454-1464, 2011. ,
DOI : 10.1158/0008-5472.CAN-10-3093
Polymalic acid-based nanobiopolymer compositions and methods for treating cancer, PCT Int Appl. WO, p.1, 2012. ,
Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer, PLoS ONE, vol.12, issue.2, pp.1-9, 2012. ,
DOI : 10.1371/journal.pone.0031070.t001
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: What should be the policy?, NeuroImage, vol.54, pp.5106-5124, 2011. ,
DOI : 10.1016/j.neuroimage.2010.01.105
-malic acid) for Drug Delivery, Bioconjugate Chemistry, vol.17, issue.2, pp.317-326, 2006. ,
DOI : 10.1021/bc0502457
URL : https://hal.archives-ouvertes.fr/hal-00857436
Polymalic acid-based multifunctional drug delivery system, PCT Int. Appl. WO, p.2, 2005. ,
Nanoconjugate based on polymalic acid for tumor targeting, Chemico-Biological Interactions, vol.171, issue.2, pp.195-203, 2008. ,
DOI : 10.1016/j.cbi.2007.01.015
Biocompatible nanopolymers: the next generation of breast cancer treatment?, Nanomedicine, vol.7, issue.10, pp.1467-1470, 2012. ,
DOI : 10.2217/nnm.12.115
Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment, J Drug Target, vol.21, issue.10, pp.956-967, 2013. ,
Temozolomide Delivery to Tumor Cells by a Multifunctional Nano Vehicle Based on Poly(??-L-malic acid), Pharmaceutical Research, vol.307, issue.11, pp.2317-2329, 2010. ,
DOI : 10.1007/s11095-010-0091-0
Drug delivery of Temozolomide for systemic based treatment of cancer, PCT Int Appl. WO, pp.72240-72241, 2011. ,
Cellular Delivery of Doxorubicin via pH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly(??-L-Malic Acid), International Journal of Molecular Sciences, vol.13, issue.12, pp.11681-11693, 2012. ,
DOI : 10.3390/ijms130911681
Nanoconjugate platforms development based in, 2010. ,
Cell specific anticancer drug delivery using poly(?malic acid)/saccharide conjugate, Proceed Intern Symp Control Rel Bioact Mater, vol.19, pp.68-69, 1992. ,
Cell-typespecific augmentation of the tumoricidal activity of polymeric adriamycin combined with galactosamine, Acta Medica Nagasakiensia, vol.43, issue.12, pp.12-15, 1998. ,
Malic acid-propane 1,2-diol copolyester as an enteric coating material, J Polym Mater, vol.19, pp.87-92, 2000. ,
Drug delivery profile of malic acid-phthalic acid-propane 1,2-diol copolyester, J Polym Mater, vol.17, pp.467-472, 2002. ,
In vitro drug release profile of malic acidbutane 1,4-diol copolyester, J Polym Mater, vol.20, pp.337-342, 2003. ,
-RS-??-malic acid), Macromolecules, vol.38, issue.20, pp.8227-8234, 2005. ,
DOI : 10.1021/ma050545j
URL : https://hal.archives-ouvertes.fr/tel-01108652
Synthesis and Degradation of Biodegradable Photo-Cross-Linked Poly(??,??-malic acid)-Based Hydrogel, Chemistry of Materials, vol.18, issue.17, pp.3946-3955, 2006. ,
DOI : 10.1021/cm0526516
Addition of ??-Malic Acid-Containing Poly(ethylene glycol) Dimethacrylate To Form Biodegradable and Biocompatible Hydrogels, Biomacromolecules, vol.10, issue.8, pp.2043-2052, 2009. ,
DOI : 10.1021/bm801367n
Synthesis and characterization of a functionalized biodegradable copolymer: poly(l-lactide-co-RS-??-malic acid), Polymer, vol.44, issue.4, pp.989-994, 2003. ,
DOI : 10.1016/S0032-3861(02)00831-5
Morphology and degradation of biodegradable poly(L-lactide-co-?-malic acid), Polymers for Advanced Technologies, vol.37, issue.9, pp.645-652, 2003. ,
DOI : 10.1002/pat.387
Synthesis and cell affinity of functionalized poly(l-lactide-co-??-malic acid) with high molecular weight, Biomaterials, vol.25, issue.22, pp.5239-5247, 2004. ,
DOI : 10.1016/j.biomaterials.2003.12.030
-RS-??-malic acid), Journal of Biomedical Materials Research Part A, vol.67, issue.1, pp.254-263, 2008. ,
DOI : 10.1002/jbm.a.31793
URL : https://hal.archives-ouvertes.fr/tel-01108652
PREPARATION AND CELL COMPATIBILITY OF FUNCTIONALIZED BIODEGRADABLE POLY(DL-LACTIDE-co-RS-??-MALIC ACID), Chinese Journal of Polymer Science, vol.26, issue.02, pp.177-186, 2008. ,
DOI : 10.1142/S0256767908002819
Blood compatibility evaluation of poly(d,l-lactide-co-beta-malic acid) modified with the GRGDS sequence, Colloids and Surfaces B: Biointerfaces, vol.75, issue.1, pp.370-376, 2010. ,
DOI : 10.1016/j.colsurfb.2009.09.011
-??-Malic Acid) with Extended Carboxyl Arms Offering Better Cell Affinity and Hemacompatibility for Blood Vessel Engineering, Tissue Engineering Part A, vol.15, issue.1, pp.65-73, 2009. ,
DOI : 10.1089/ten.tea.2007.0394
The preparation of sub-200 nm biodegradable colloidal particles from poly(??-malic acid-co-benzyl malate) copolymers and their surface modification with Poloxamer and Poloxamine surfactants, Journal of Controlled Release, vol.30, issue.1, pp.57-67, 1994. ,
DOI : 10.1016/0168-3659(94)90044-2
The colloidal properties of surfactant-free biodegradable nanospheres from poly(?-malic acid-co-benzyl malate)s and poly(lactic acid-co-glycolide)Colloids and Surfaces A: Physicochemical and Engineering Aspects, pp.235-245, 1995. ,
Nanospheres prepared from poly(?-malic acid) benzyl ester copolymers: evidence for their in vitro degradation, Journal of Materials Science: Materials in Medicine, vol.4, issue.3, pp.161-166, 1996. ,
DOI : 10.1007/BF00121255
Effects of complexation between liposome and poly(malic acid) on aggregation and leakage behaviour, Biomaterials, vol.21, issue.9, pp.867-876, 2000. ,
DOI : 10.1016/S0142-9612(99)00210-0
Fully biodegradable polymeric micelles based on hydrophobic- and hydrophilic-functionalized poly(lactide) block copolymers, Journal of Polymer Science Part A: Polymer Chemistry, vol.126, issue.15, pp.3244-3254, 2010. ,
DOI : 10.1002/pola.24100
URL : https://hal.archives-ouvertes.fr/hal-00519455
Synthesis and characterization of a functionalized amphiphilic diblock copolymer: MePEG-b-poly(DL-lactide-co-RS-??-malic acid), Colloid and Polymer Science, vol.28, issue.3, pp.273-281, 2006. ,
DOI : 10.1007/s00396-006-1560-1
Biodegradable magnetic-fluorescent magnetite/poly(dl-lactic acid-co-??,??-malic acid) composite nanoparticles for stem cell labeling, Biomaterials, vol.31, issue.13, pp.3502-3511, 2010. ,
DOI : 10.1016/j.biomaterials.2010.01.081
Polymer coated magnetic particles, PCT Int Appl. WO, vol.2011053252, issue.A1, 2011. ,
Physicochemical Characteristics and Preliminary in Vivo Biological Evaluation of Nanocapsules Loaded with siRNA Targeting Estrogen Receptor Alpha, Biomacromolecules, vol.9, issue.10, pp.2881-2890, 2008. ,
DOI : 10.1021/bm800664c
Tumor-Targeting, pH-Responsive, and Stable Unimolecular Micelles as Drug Nanocarriers for Targeted Cancer Therapy, Bioconjugate Chemistry, vol.21, issue.3, pp.496-504, 2010. ,
DOI : 10.1021/bc900422j
Biodegradable Nanoparticles Based on Linoleic Acid and Poly(??-malic acid) Double Grafted Chitosan Derivatives as Carriers of Anticancer Drugs, Biomacromolecules, vol.10, issue.3, pp.565-572, 2009. ,
DOI : 10.1021/bm801225m
Effects of hydrophobic and hydrophilic modifications on gene delivery of amphiphilic chitosan based nanocarriers, Biomaterials, vol.32, issue.20, pp.4630-4638, 2011. ,
DOI : 10.1016/j.biomaterials.2011.03.003
Preparation and pH controlled release of polyelectrolyte complex of poly(l-malic acid-co-d,l-lactic acid) and chitosan, Colloids and Surfaces B: Biointerfaces, vol.115, pp.275-279, 2014. ,
DOI : 10.1016/j.colsurfb.2013.12.018
Stereocomplexation in novel degradable amphiphilic block copolymer micelles of poly(ethylene oxide) and poly(benzyl ??-malate), Soft Matter, vol.9, issue.22, pp.10987-10993, 2011. ,
DOI : 10.1039/C1PY00254F
Biocompatible and Biodegradable Polymeric Nanocapsules from Poly(<I>??</I>,<I>??</I>-malic acid)-Grafted Nano-silica Templates, Designed Monomers & Polymers, vol.14, issue.1, pp.39-45, 2011. ,
DOI : 10.1163/138577210X541187
Solubilization of Water-Insoluble Drugs Due to Random Amphiphilic and Degradable Poly(dimethylmalic acid) Derivatives, Biomacromolecules, vol.14, issue.6, pp.1936-1944, 2013. ,
DOI : 10.1021/bm400323c
URL : https://hal.archives-ouvertes.fr/hal-01003204
Synthesis and Characterization of New Malolactonate Polymers and Copolymers for Biomedical Applications, Macromolecules, vol.35, issue.4, pp.1215-1223, 2002. ,
DOI : 10.1021/ma0111257
New functional and bio-degradable nanoparticles based on poly(malic acid) derivates for site-specific anti-cancer drug delivery, Int J Pharm, vol.243, pp.84-92, 2012. ,
Degradable and biocompatible nanoparticles decorated with cyclic RGD peptide for efficient drug delivery to hepatoma cells in vitro, International Journal of Pharmaceutics, vol.454, issue.2, pp.727-737, 2013. ,
DOI : 10.1016/j.ijpharm.2013.05.060
URL : https://hal.archives-ouvertes.fr/hal-00861299
Investigation of the Degradation Mechanisms of Poly(malic acid) Esters in Vitro and Their Related Cytotoxicities on J774 Macrophages, Biomacromolecules, vol.5, issue.1, pp.137-143, 2004. ,
DOI : 10.1021/bm0300608
Nanotechnology for therapy and imaging of liver diseases, Journal of Hepatology, vol.55, issue.6, pp.1461-1466, 2011. ,
DOI : 10.1016/j.jhep.2011.05.039
Versatile and Efficient Targeting Using a Single Nanoparticulate Platform: Application to Cancer and Alzheimer???s Disease, ACS Nano, vol.6, issue.7, pp.5866-5879, 2012. ,
DOI : 10.1021/nn3004372
Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery, Biomaterials, vol.30, issue.5, pp.859-866, 2009. ,
DOI : 10.1016/j.biomaterials.2008.09.056
Biotin-conjugated block copolymeric nanoparticles as tumor-targeted drug delivery systems, Macromolecular Research, vol.12, issue.7, pp.646-655, 2007. ,
DOI : 10.1007/BF03218945
Targeting cancer cells with biotin???dendrimer conjugates, European Journal of Medicinal Chemistry, vol.44, issue.2, pp.862-868, 2009. ,
DOI : 10.1016/j.ejmech.2008.04.021